Chemoinformaics analysis of (-)-Isoelaeocarpiline
| Molecular Weight | 328.449 | nRot | 14 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 1 |
| Exact Molecular Weight | 328.225 | nRing | 0 |
| Solubility: LogS | -7.245 | nHRing | 0 |
| Solubility: LogP | 10.958 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 55.4074 |
| nHD | 4 | BPOL | 32.9706 |
| QED | 0.149 |
| Synth | 1.678 |
| Natural Product Likeliness | 0.292 |
| NR-PPAR-gamma | 0.761 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -5.168 |
| MDCK | 0.00000469 |
| BBB | 0.006 |
| PPB | 0.979251 |
| VDSS | 3.039 |
| FU | 0.00827662 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.152 |
| CYP2c19-inh | 0.122 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.038 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.083 |
| CYP2d6-sub | 0.041 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.018 |
| CL | 4.753 |
| T12 | 0.077 |
| hERG | 0.459 |
| Ames | 0.005 |
| ROA | 0.015 |
| SkinSen | 0.954 |
| Carcinogencity | 0.022 |
| EI | 0.912 |
| Respiratory | 0.883 |
| NR-Aromatase | 0.078 |
| Antiviral | Yes |
| Prediction | 0.743692 |